Bio-Med Investments II Settles with NH Securities Bureau for $2,500

STATE OF NEW HAMPSHIRE DEPARTMENT OF STATE BUREAU OF SECURITIES REGULATION CONCORD, NEW HAMPSHIRE IN THE MATTER OF: ) ) Bio-Med Investments II, LLC ) 1-2026000002 ) ) RESPONDENT ) CONSENT ORDER I. For purposes ofsettling the above-referenced matter and in lieu of further administrative proceedings, Bio-Med Investments II, LLC (hereinafter referred to as "Bio-Med II"), has submitted an offer ofsettlement, which the Bureau ofSecurities Regulation, Department ofState, State ofNew Hampshire (hereinafter referred to as "the Bureau") has detennined to accept. Accordingly, Bio-Med II, without admitting or denying the allegations or findings contained herein, does hereby consent to the entry ofthis Order and the following undertakings and sanctions: The Facts I. On May 2, 2024, Bio-Med II made the first sale ofits securities in this state to a New Hampshire resident. 2. On March 2, 2026, Bio-Med II sent a notice tiling to the Bureau relying on the exemptions from securities registration provided by Rule 506 ofRegulation D under the Securities Act of 1933, as amended, and New Hampshire RSA 421-B:3-302. 3. The notice filing was received by the Bureau on March 4, 2026. Analysis 4. Pursuant to RSA 421-B:3-30 I, it is unlawful for any person to offer or sell any security in this state unless the security is registered pursuant to RSA 421-B; the security, offer, or transaction is exempt under RSA 421-B:2-20 I through 2-203; or the security is federally covered. Respondent Bio-Med II is subject to this provision. 5. Pursuant to RSA l-B:3-302, Bio-Med II, which sold a federal covered security as described in section 18(b)(4)(F) ofthe Securities Act of l 933, was required to notice file

with the Bureau within fifteen (15) days ofthe first sale in New Hampshire. Yet, as outlined above, Bio-Med [I filed its notice filing on March 2, 2026, more than one year after the first sale of covered securities in New Hampshire. 6. Pursuant to RSA 42 I-B:6-614( d)(2), any notice filing delinquent by more than one (I) year may be subject to the fines and penalties outlined in RSA 42 l-B:6-603, 6-604, and 5-508. Respondent Bio-Med II is subject to this provision. H. ln view of the foregoing, Respondent agrees to the following undertakings and sanctions: I. Respondent Bio-Med II agrees that it has voluntarily consented to the entry ofthis Order and represents and avers that no employee or representative ofthe Bureau has made any promise, representation, or threat to induce its execution. 2. Respondent Bio-Med II agrees to waive its right to an administrative hearing and any appeal therein under this chapter. 3. Respondent Bio-Med II agrees that this Order is entered into for the purpose ofresolving only the matter as described herein. This Order shall have no collateral estoppel, res judicata, or evidentiary effect in any other lawsuit, proceeding, or action, not described herein. l,ikewise, this Order shall not be construed to restrict the Bureau's right to initiate an administrc1tive investigation or proceeding relative to conduct by Respondent which the Bureau has no knowledge at the time ofthe date of final entry ofthis Order. 4. Respondent Bio-Med II agrees not to take any action or make or pennit to he made any public statement, including in regulatory filings or otherwise, denying, directly or indirectly, any allegation in this Consent Order or create the impression that the Consent Order is without factual basis. Nothing in this provision affects Respondent's testimonial obligations or right to take legal positions in litigation in which the State ofNew Hampshire is not a party. 5. Respondent Bio-Med II agrees to cease and desist from further violations ofRSA 421- B:3-302(c). 6. Respondent Bio-Med II agrees to submit payment lo the State of New Hampshire representing administrative penalties in the amount oftwo thousand five hundred dollars ($2,500). 7. Upon execution ofthis Order by Respondent Bio-Med II, Respondent agrees to pay a total oftwo thousand five hundred dollars ($2,500) to the State of New Hampshire, which

will be applied to settlement ofthe above-captioned matter. Payment must be made by 1) business check, certified check, or postal money order; 2) made payable to the State of New Hampshire; and 3) mailed to the Bureau ofSecurities Regulation, Department of State 107 North Main St, Room 204, Concord, NH 03301. 8. This Order is not intended to indicate that Respondent Bio-Med II should be subject to any statutory disqualifications set forth in (a) the federal securities laws or regulations promulgated thereunder, (b) the rules and regulations ofany self-regulatory organization, or (c) various states' securities laws, including any disqualifications from relying on exemptions from registration or associated safe harbor provisions. The Bureau confirms that disqualification under 17 C.F.R. § 230.506(d)(l )(iii) should not arise, and is not intended to arise, as a consequence of this Order. III. Based on the foregoing, the Bureau deems it appropriate and in the public interest to accept and enter into this Order. THEREFORE, IT IS HEREBY ORDERED THAT: 1. Respondent cease and desist from further violations of RSA 421-B:3-302(c). 2. Respondent pay administrative penalties in the amount oftwo thousand five hundred dollars ($2,500). 3. Respondent comply with the above-referenced undertakings and sanctions. Executed this _ 12 _ day ofMar ch___, 2026. On fufBtInvestments II, LLC (Please print name below) Dick Anagnost, Manager Entered this o.±_~xfay of ((J..r ~ , 2026. Eric Forcier, Director N.H. Bureau of Securities Regulation